Women with a history of preeclampsia should be monitored for the onset and progression of chronic kidney disease

Nature Clinical Practice Nephrology

Volumn 5, Issue 1, 2009, Pages 8-9

  Hamano, Takayuki ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cardiovascular disease; Endothelial dysfunction; Endotheliosis; Preeclampsia; VEGF

Indexed keywords

BEVACIZUMAB; PLACENTAL GROWTH FACTOR; VASCULOTROPIN;

ANAMNESIS; BLOOD PRESSURE MEASUREMENT; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; ESSENTIAL HYPERTENSION; FOLLOW UP; GLOMERULONEPHRITIS; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY INJURY; LOW BIRTH WEIGHT; NOTE; PATIENT MONITORING; PREECLAMPSIA; PREMATURITY; PRIORITY JOURNAL; PROTEINURIA; RENAL PROTECTION; RHEUMATIC DISEASE; RISK ASSESSMENT; RISK REDUCTION;

EID: 57749204347     PISSN: 17458323     EISSN: 17458331     Source Type: Journal    
DOI: 10.1038/ncpneph0991     Document Type: Note

References (8)

1. Vikse BE et al. (2008) Preeclampsia and the risk of end-stage renal disease. N Engl J Med 359: 800-809
2. Hertig A et al. (2008) How should women with pre-eclampsia be followed up? New insights from mechanistic studies. Nat Clin Pract Nephrol 4: 503-509
3. Vikse BE et al. (2006) Adverse perinatal outcome and later kidney biopsy in the mother. J Am Soc Nephrol 17: 837-845
4. Maynard SE et al. (2003) Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111: 649-658
5. Sugimoto H et al. (2003) Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria. J Biol Chem 278: 12605-12608
6. Eremina V et al. (2003) Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J Clin Invest 111: 707-716
7. Eremina V et al. (2008) VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med 358: 1129-1136
8. Hamad RR et al. (2007) Decreased flow-mediated dilatation is present 1 year after pre-eclamptic pregnancy. J Hypertens 25: 2301-2307